Published in Surgery on August 01, 1979
Efficacy of an elective regional lymph node dissection of 1 to 4 mm thick melanomas for patients 60 years of age and younger. Ann Surg (1996) 2.68
A comparison of prognostic factors and surgical results in 1,786 patients with localized (stage I) melanoma treated in Alabama, USA, and New South Wales, Australia. Ann Surg (1982) 2.09
A multifactorial analysis of melanoma: III. Prognostic factors in melanoma patients with lymph node metastases (stage II). Ann Surg (1981) 2.09
Prognostic factors for melanoma patients with lesions 0.76 - 1.69 mm in thickness. An appraisal of "thin" level IV lesions. Ann Surg (1982) 1.72
Long-term follow-up and survival of patients following a recurrence of melanoma after a negative sentinel lymph node biopsy result. JAMA Surg (2013) 1.50
Clinical significance of occult metastatic melanoma in sentinel lymph nodes and other high-risk factors based on long-term follow-up. World J Surg (2005) 1.47
The extent of primary melanoma excision. A re-evaluation--how wide is wide? Ann Surg (1983) 1.45
A prognostic model for clinical stage I melanoma of the upper extremity. The importance of anatomic subsites in predicting recurrent disease. Ann Surg (1981) 1.38
Prognostic factors for patients with clinical stage I melanoma of intermediate thickness (1.51 - 3.39 mm). A conceptual model for tumor growth and metastasis. Ann Surg (1982) 1.38
Malignant melanoma. Prognostic significance of "microscopic satellites" in the reticular dermis and subcutaneous fat. Ann Surg (1981) 1.34
Gender-related differences in outcome for melanoma patients. Ann Surg (2006) 1.32
Efficacy of elective lymph node dissection in patients with intermediate thickness primary melanoma. Ann Surg (1983) 1.26
A multivariate analysis of prognostic factors for melanoma patients with lesions greater than or equal to 3.65 mm in thickness. The importance of revealing alternative Cox models. Ann Surg (1982) 1.24
Prognostic significance of DNA aneuploidy in stage I cutaneous melanoma. Ann Surg (1988) 1.19
Melanoma recurrence surveillance. Patient or physician based? Ann Surg (1995) 1.03
Metastasis and death in patients with thin melanomas (less than 0.76 mm). Ann Surg (1983) 1.01
Sentinel node biopsy in melanoma: technical considerations of the procedure as performed at the John Wayne Cancer Institute. J Surg Oncol (2010) 1.00
Malignant melanoma. Practical considerations concerning prophylactic regional lymph node dissection. Ann Surg (1987) 0.96
Head and neck melanoma in 534 clinical Stage I patients. A prognostic factors analysis and results of surgical treatment. Ann Surg (1984) 0.93
Age as a predictor of sentinel node metastasis among patients with localized melanoma: an inverse correlation of melanoma mortality and incidence of sentinel node metastasis among young and old patients. Ann Surg Oncol (2014) 0.91
Age as a prognostic factor in patients with localized melanoma and regional metastases. Ann Surg Oncol (2013) 0.90
Cutaneous malignant melanoma in West Yorkshire: I. A prospective study of variables, survival and prognosis. Br J Cancer (1983) 0.86
Selective surgical management of cutaneous melanoma of the head and neck. Ann Surg (1980) 0.82
Biopsy procedures, primary wide excisional surgery and long term prognosis in primary clinical stage I invasive cutaneous malignant melanoma. Ann R Coll Surg Engl (1985) 0.82
Microenvironment-derived factors driving metastatic plasticity in melanoma. Nat Commun (2017) 0.81
General surgery-important advances in clinical medicine: cutaneous melanoma. West J Med (1983) 0.78
Parametric modeling of localized melanoma prognosis and outcome. J Biopharm Stat (2009) 0.78
Surgery as palliative treatment for distant metastases of melanoma. Ann Surg (1986) 0.77
Thin (less than or equal to 1 mm) melanomas of the extremities are biologically favorable lesions not influenced by regression. Ann Surg (1985) 0.77
Prognostic significance in malignant melanoma of nuclear DNA content measured by a microfluorimetric method. Arch Dermatol Res (1995) 0.75
Primary malignant melanoma of the rectum: report of two cases. Case Rep Surg (2012) 0.75
Review of general surgery 1979. Postgrad Med J (1980) 0.75
Prognostic factors analysis of 17,600 melanoma patients: validation of the American Joint Committee on Cancer melanoma staging system. J Clin Oncol (2001) 10.20
Final version of the American Joint Committee on Cancer staging system for cutaneous melanoma. J Clin Oncol (2001) 9.68
A differentiation antigen of human NK and K cells identified by a monoclonal antibody (HNK-1). J Immunol (1981) 8.17
Adenine arabinoside therapy of biopsy-proved herpes simplex encephalitis. National Institute of Allergy and Infectious Diseases collaborative antiviral study. N Engl J Med (1977) 5.02
Vidarabine versus acyclovir therapy in herpes simplex encephalitis. N Engl J Med (1986) 4.37
Acyclovir with and without prednisone for the treatment of herpes zoster. A randomized, placebo-controlled trial. The National Institute of Allergy and Infectious Diseases Collaborative Antiviral Study Group. Ann Intern Med (1996) 4.28
A multifactorial analysis of melanoma. IV. Prognostic factors in 200 melanoma patients with distant metastases (stage III). J Clin Oncol (1983) 3.80
Multi-institutional melanoma lymphatic mapping experience: the prognostic value of sentinel lymph node status in 612 stage I or II melanoma patients. J Clin Oncol (1999) 3.74
A multifactorial analysis of melanoma: prognostic histopathological features comparing Clark's and Breslow's staging methods. Ann Surg (1978) 2.94
Natural history of neonatal herpes simplex virus infections in the acyclovir era. Pediatrics (2001) 2.91
Vidarabine therapy of neonatal herpes simplex virus infection. Pediatrics (1980) 2.70
Efficacy of an elective regional lymph node dissection of 1 to 4 mm thick melanomas for patients 60 years of age and younger. Ann Surg (1996) 2.68
Characterization of HNK-1+ (Leu-7) human lymphocytes. I. Two distinct phenotypes of human NK cells with different cytotoxic capability. J Immunol (1982) 2.63
Herpes simplex encephalitis: vidarabine therapy and diagnostic problems. N Engl J Med (1981) 2.56
Tumor thickness as a guide to surgical management of clinical stage I melanoma patients. Cancer (1979) 2.41
Diseases that mimic herpes simplex encephalitis. Diagnosis, presentation, and outcome. NIAD Collaborative Antiviral Study Group. JAMA (1989) 2.38
Adjuvant therapy of stage III and IV malignant melanoma using granulocyte-macrophage colony-stimulating factor. J Clin Oncol (2000) 2.37
Postnatal expansion of the natural killer and keller cell population in humans identified by the monoclonal HNK-1 antibody. J Exp Med (1982) 2.35
Critical analysis of the current American Joint Committee on Cancer staging system for cutaneous melanoma and proposal of a new staging system. J Clin Oncol (1997) 2.32
Safety and efficacy of high-dose intravenous acyclovir in the management of neonatal herpes simplex virus infections. Pediatrics (2001) 2.30
Improved staging of node-negative patients with intermediate to thick melanomas (>1 mm) with the use of lymphatic mapping and sentinel lymph node biopsy. Ann Surg Oncol (2001) 2.19
A comparison of prognostic factors and surgical results in 1,786 patients with localized (stage I) melanoma treated in Alabama, USA, and New South Wales, Australia. Ann Surg (1982) 2.09
A multifactorial analysis of melanoma: III. Prognostic factors in melanoma patients with lymph node metastases (stage II). Ann Surg (1981) 2.09
Long-term results of a prospective surgical trial comparing 2 cm vs. 4 cm excision margins for 740 patients with 1-4 mm melanomas. Ann Surg Oncol (2001) 2.06
Leu-11+ lymphocytes with natural killer (NK) activity are precursors of recombinant interleukin 2 (rIL 2)-induced activated killer (AK) cells. J Immunol (1985) 2.03
Autologous tumor-specific cytotoxic T lymphocytes in the infiltrate of human metastatic melanomas. Activation by interleukin 2 and autologous tumor cells, and involvement of the T cell receptor. J Exp Med (1988) 1.98
Patterns of recurrence following a negative sentinel lymph node biopsy in 243 patients with stage I or II melanoma. J Clin Oncol (1998) 1.92
Recent advances in the care of the patient with malignant melanoma. Ann Surg (1997) 1.92
Conventional TRAM flap versus free microsurgical TRAM flap for immediate breast reconstruction. Plast Reconstr Surg (1989) 1.87
Herpes simplex encephalitis. Clinical Assessment. JAMA (1982) 1.83
Role of the pericyte in wound healing. An ultrastructural study. Exp Mol Pathol (1970) 1.78
Changing presentation of herpes simplex virus infection in neonates. J Infect Dis (1988) 1.76
A randomized trial to improve self-management practices of adults with asthma. Arch Intern Med (1990) 1.67
The prognostic significance of ulceration of cutaneous melanoma. Cancer (1980) 1.66
Prophylactic lymph node dissection in clinical stage I cutaneous malignant melanoma: results of surgical treatment in 1319 patients. Br J Surg (1982) 1.62
Phase specific analysis of herpes zoster associated pain data: a new statistical approach. Stat Med (2001) 1.60
Suppressor cell function of human granular lymphocytes identified by the HNK-1 (Leu 7) monoclonal antibody. J Immunol (1983) 1.60
Factors affecting survival following local, regional, or distant recurrence from localized melanoma. J Surg Oncol (1998) 1.57
Foreign bodies in the appendix. Report of eight cases and review of the literature. Arch Surg (1971) 1.55
A new American Joint Committee on Cancer staging system for cutaneous melanoma. Cancer (2000) 1.52
Predictors of sun exposure in adolescents in a southeastern U.S. population. J Adolesc Health (1996) 1.50
The ultrastructure of medullary and scirrhous mammary duct carcinoma. Am J Pathol (1967) 1.50
Oral acyclovir therapy accelerates pain resolution in patients with herpes zoster: a meta-analysis of placebo-controlled trials. Clin Infect Dis (1996) 1.50
Interleukin 2 activation of cytotoxic T-lymphocytes infiltrating into human metastatic melanomas. Cancer Res (1986) 1.50
Differentiation stages of human natural killer cells in lymphoid tissues from fetal to adult life. J Exp Med (1983) 1.48
Cranial irradiation after surgical excision of brain metastases in melanoma patients. Ann Surg Oncol (1996) 1.48
A multifactorial analysis of prognostic factors in patients with liver metastases from colorectal carcinoma. J Clin Oncol (1983) 1.46
Second-look laparotomy and salvage therapy: a research modality only? Gynecol Oncol (1992) 1.45
A prospective phase II clinical trial of continuous FUDR regional chemotherapy for colorectal metastases to the liver using a totally implantable drug infusion pump. Ann Surg (1983) 1.45
Corynebacterium parvum versus bacille Calmette-Guérin adjuvant immunotherapy of stage II malignant melanoma. J Clin Oncol (1991) 1.42
The prognostic significance of lymph node metastases after preoperative chemotherapy for locally advanced breast cancer. Arch Surg (1989) 1.41
Administration of oral acyclovir suppressive therapy after neonatal herpes simplex virus disease limited to the skin, eyes and mouth: results of a phase I/II trial. Pediatr Infect Dis J (1996) 1.41
What is a surgical oncologist? Ann Surg Oncol (1994) 1.40
How patient referral bias can confuse interpretation of clinical results: elective lymph node dissections at the Sydney Melanoma Unit. J Am Coll Surg (1995) 1.39
The needle biopsy should replace open excisional biopsy ... but will the surgeon's role in coordinating breast cancer treatment be diminished? Ann Surg Oncol (1995) 1.39
Prognostic histopathological factors in malignant melanoma. Pathology (1985) 1.39
Think melanoma. South Med J (1993) 1.39
Characterization of HNK-1+ (Leu-7) human lymphocytes. II. Distinguishing phenotypic and functional properties of natural killer cells from activated NK-like cells. J Immunol (1982) 1.38
Isolation and partial characterization of the human homologue of Thy-1. J Exp Med (1980) 1.34
Surgery for abdominal metastases of cutaneous melanoma. World J Surg (2001) 1.33
Relationships between socioeconomic status and race-specific cervical cancer incidence in the United States, 1973-1992. J Health Care Poor Underserved (1998) 1.31
Treatment of secondary hyperparathyroidism in patients with chronic renal failure by total parathyroidectomy and parathyroid autograft. Ann Surg (1981) 1.30
Prognostic factors for survival of patients treated systemically for disseminated melanoma. J Clin Oncol (1998) 1.29
Ultrastructure of a hemangiopericytoma and a glomus tumor. Cancer (1968) 1.29
Early vidarabine therapy to control the complications of herpes zoster in immunosuppressed patients. N Engl J Med (1982) 1.27
Involvement of the cytotoxic/suppressor T-cell subset in liver tissue injury of patients with acute and chronic liver diseases. Gastroenterology (1983) 1.26
Survival following locoregional recurrence after breast conservation therapy for cancer. Ann Surg (1990) 1.25
The influence of surgical margins and prognostic factors predicting the risk of local recurrence in 3445 patients with primary cutaneous melanoma. Cancer (1985) 1.24
Suppression of immunoglobulin synthesis by lymphocyte subpopulations in patients with Crohn's disease. Gastroenterology (1984) 1.22
Ultrastructure of myoepithelial cells in human mammary gland tumors. Cancer (1968) 1.21